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Abstract 
During the last months, there has been a significant increase in the evidence showing the catastrophic health situation in Venezuela. There are multiple epidemics, 
increase in emerging and reemerging infectious, tropical and parasitic diseases as consequences of the social, economic and political crises, which would be 
considered today an anthropogenic disaster. Venezuela is facing in 2019, the worse sanitary conditions, with multiple implications for public health and travel 
medicine. So far, from a global perspective, this situation will be an impediment for the achievement of sustainable development goals (SDG) in 2030. In this 
multiauthor review, there is a comprehensive analysis of the situation for infectious diseases, non-communicable diseases, their impact in the Americas region, 
given the migration crisis as well as the relative status of the SDG 2030. This discussion can provide input for prioritizing emerging health problems and establish 
a future agenda.  
 
Key words: Infectious diseases, tropical diseases, epidemics, parasitic diseases, syndemics, sustainable development goals, anthropogenic disaster, political 
crisis, migratory crisis, Venezuela. 
 
Suárez et al –Anthropogenic Disasters and Infectious Diseases in Venezuela 2019 
74 
 
 
Rev Panam Enf Inf 2018; 1(2):73-93. 
20Servicio de Anatomía Patológica, Complejo Hospitalario Universitario de Albacete, Facultad de Medicina Universidad Castilla La 
Mancha, Albacete, Spain. 
21Infectious Diseases and Infection Control Research Group, Hospital Universitario de Sincelejo, Sincelejo, Sucre, Colombia. 
22Programa del Doctorado de Medicina Tropical, Universidad del Atlántico, Barranquilla, Colombia. 
23Clinical Department, Escuela de Bioanálisis, Faculty of Health Sciences, Universidad de Carabobo, Valencia, Venezuela. 
24Universidad Técnica de Ambato, Ambato, Ecuador. 
25Clinique Les Hauts d'Anieres, Geneva, Switzerland. 
26Universidad Estatal del Sur de Manabí, Cantón Jipijapa, Ecuador. 
27Universidad Nacional Autónoma de Nicaragua (UNAN), Managua, Nicaragua. 
28ICOH National Secretary, Caracas, Venezuela. 
29Consultorio Médico de Especialidades, Montevideo, Uruguay.  
30Capítulo Merideño, Sociedad Venezolana de Medicina Interna, Mérida, Venezuela. 
31Hospital Universitario Fundación Jiménez Diaz, Madrid, Spain. 
32Universidad Católica Santa María la Antigua, Panama city, Panama. 
33Laboratorio de Neurociencias, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile. 
34Hospital Evangélico de Montevideo, Montevideo, Uruguay. 
35Institute of Infectious Diseases 'Emilio Ribas', São Paulo, Brazil. 
36Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 
37Division of Infectious Diseases, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora CO, USA. 
38Hospital Infantil de México, Federico Gómez, México City, México. 
39Colombiana de Trasplantes, Sede Rionegro, Antioquia, Colombia.  
40Surgery Area, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Colombia. 
41Grupo de Investigación en Ciencias Animales-GRICA, Universidad Cooperativa de Colombia, Calle 30A #, 33-51, Bucaramanga, 
Colombia 
42Infectious Diseases Division, Instituto Nacional de Salud del Niño San Borja, Lima, Peru. 
43Hospital Universitario Departamental de Nariño, Pasto, Nariño, Colombia 
44Coordination of Microbiology, School of Medicine, Universidad de Manizales, Manizales, Caldas, Colombia. 
45Grupo de Resistencia Antibiótica de Manizales (GRAM), Manizales, Caldas, Colombia. 
46Clínica San José, Cúcuta, Norte de Santander, Colombia. 
47Hospital Universitario Erasmo Meoz, Cúcuta, Norte de Santander, Colombia.  
48Grupo de Investigación Biomedicina, Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, 660004, Colombia.  
49Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, 
Colombia. 
50Grupo de Investigación Infección e Inmunidad, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, 
Colombia. 
51Grupo de Investigación en Enfermedades Emergentes y Medicina Tropical, Instituto para la Investigación en Ciencias Biomédicas – Sci-
Help, Pereira, Risaralda, Colombia. 
52Grupo de Investigación en Ciencias Animales (GISCA), Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, 660004, 
Colombia.  
53Editor-in-Chief, Revista Panamericana de Enfermedades Infecciosas, Asociación Panamericana de Infectología. 
 
Conflict of interest. Opinions expressed in this editorial are not necessarily the position of the author’s institutions but of the authors. 
Funding. None. 
◊Contents of this review were previously presented in part at the I International Congress of Tropical Diseases of the Colombian Association of Infectious 
Diseases (ACINTROP 2019), Montería, Córdoba, Colombia, March 21-22, 2019 (Opening Plenary Lecture – AJ Rodriguez-Morales). Also, at the XIX Pan-
American Congress of Infectious Diseases 2019.    
Introduction 
Over the last two decades, many Venezuelan citizens 
have suffered a drastic reduction in their standard of 
living, and overall health and quality of life [1-5]. The 
ongoing political, social and economic crises have 
exponentially accelerated as multiple scientific reports, 
and media outlet has recently illustrated in the last few 
months [6].  
The impact of this humanitarian crisis has led to 
significant social injustices including health inequities 
and enabled downward social mobility of already 
marginalized and impoverished populations [4, 5, 7-16]. 
According to different estimates, by the end of 2018 and 
the beginning of 2019, more than 4 million impoverished 
Venezuelans have crossed international borders by air, 
land, and in some cases by sea and even by foot, carrying 
a couple of suitcases with their most personal belongings. 
In August 2018, the International Organization for 
Migration (IOM), said: “This is building to a crisis 
moment that we have seen in other parts of the world, 
particularly in the Mediterranean” [17].  
Newspapers as well as non-governmental 
organizations (NGO), all around the world, claim this is 
the largest migration crisis in the history of Latin 
America escaping the increasing disparities and low 
standard of living conditions [7, 9]. By the end of 2019, 
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the number of Venezuelan migrants will reach the 6 
million mark [18]. In fact, some international 
organizations, such as the Food and Agriculture 
Organization of the United Nations and the European 
Commission have defined the situation of Venezuela as 
a “complex crisis”, which not only includes political and 
socio-economic topics but also affects health and food 
security, related to a poor accessibility and availability to 
food [19].  
Undeniably, as explained in detail later, the political 
actions of the last two governments in the country have 
led to the profound economic, political, food security and 
social crisis with a high impact in health. Even, members 
of Cuba’s medical missions to Venezuela —a signature 
element of relations between the two countries— 
described a system of deliberate political manipulation in 
which their services were wielded to secure votes for the 
governing Socialist Party, often through coercion, 
according to the New York Times [20]. 
Growing poverty levels, according to the National 
Survey of Living Conditions [ENCOVI] 2016, using the 
multidimensional poverty index, the proportion of 
households living in poverty increased reaching 46% in 
2016, being higher outside the capital city Caracas, [21], 
and leading between 2014 to 2017 to a significant 
increase especially in total poverty (87%) and extreme 
poverty indexes (61.2%) (Figure 1) [17, 21].  
 
Figure 1. Poverty by the level of income, according to 
ENCOVI, Venezuela, 2014-2017. Modified from [17, 21]. 
 
 
Also, food insecurity (for 2016, according to 
ENCOVI, 32.5% of the people had two or fewer foods 
per day, 39.8 among those considered in extreme 
poverty) [21], and escalating violence are the driving 
forces underlying the massive exodus across the 
Venezuelan borders. The already precarious public 
health infrastructure (presence of stray pets in health 
centers, rusty stretchers, leaking ceilings, lack of 
cleaning products in hospitals and poor sanitary disposal) 
combined with a collapsed healthcare systems failure 
have resulted in a double burden of disease characterized 
by the resurgence of previously controlled infectious 
diseases [22, 23], and multiple simultaneous epidemics 
(syndemics) [8].  
Additionally, food shortages have resulted in 
unprecedented degrees of malnutrition [22, 23]. Failure 
of the social security institutions along with the 
deterioration of the rule of law has led to dramatic 
increases in violent crime such as homicide, armed 
robbery, kidnapping, and carjacking [2, 24, 25]. 
Throughout the country, impoverished and marginalized 
Venezuelans often experience power outages, water 
shortages and limited availability of essential 
medications and medical supplies [23].  
The global perception of the civil strife and the 
prevailing insecurity in Venezuela prompted the U.S. 
Centers for Disease Control and Prevention (CDC) to 
issue a warning Level 3 for international travelers to 
avoid non-essential travel to Venezuela since May 2018 
[26]. Furthermore, the Venezuelan government restricts 
access to U.S. consular services for individuals with 
double nationality (U.S. and Venezuelan), and on March 
2019 the U.S. Embassy in Caracas closed all its services, 
and all the diplomatic personnel was withdrawn and sent 
back to the USA.  
Residents of Caracas and another major Venezuelan 
cities recently experienced a seven-day-long power 
outage and limited water supply that further hampered 
sanitation efforts enabling the spread of infectious 
pathogens [27, 28]. Therefore, at this time, international 
travelers entering Venezuela during essential trips need 
to seek detailed pre-travel advice as well as to register at 
their country consulate at the time of entry to receive 
specific safety and security recommendations. 
It is difficult to estimate the magnitude of the health 
problem associated with migration, as well as to 
recognize the mechanisms involved. Due to the growing 
volume of migrants, we still do not have yet enough 
reliable denominators to estimate the risk of each disease 
among migrants in the receiving countries.  
For these reasons, the increase in health events in 
Venezuelan migrants is restricted to the perspective of 
the provision of services and surveillance systems.  
Consequently, it should be noted that the rise in each 
of the health problems identified in migrants would be 
the result of one or more of the following phenomena: 
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A) The expected increase due to the brute migratory 
population growth, which would be related to the 
demographic structure of the population that enters the 
country. For example, the migration of older adults will 
lead to an increase in the demand for services for chronic 
disease care, without necessarily implying that this group 
has a higher risk than those of the same age in the 
receiving country. 
B) The selective migration of groups with specific 
risk factors. For example, in the case that people who 
migrate have particular conditions, such as malnutrition 
or risk behavior, this group will contribute to an increase 
in cases higher than expected for their demographic 
characteristics. 
C) The spread of emerging or reemerging health 
problems, originated or promoted in the country of origin 
(in this case Venezuela), related or not to the 
aforementioned socioeconomic crisis. For example, the 
importation of vaccine-preventable diseases from 
regions with low vaccination coverage. 
At this time, we cannot determine which one or more 
of these three mechanisms predominate in the emergence 
of each one of the health problems identified among 
migrants. However, the purpose of this article is to 
review the events in which the representation of 
Venezuelan immigrants has increased and discuss 
possible explanations related to the humanitarian crisis 
of recent years. 
 
An anthropogenic disaster 
The humanitarian crisis in Venezuela is the result of 
poor governance stemming from failed social and 
economic policies [29]. Devalued appreciations of the 
moral and the political economy of human life have 
resulted in limited freedoms and opportunities for 
Venezuelan citizens. Providing medical care and 
attending to public health demands has become a 
significant commodity leading to unnecessary human 
suffering and substantial material and economic losses. 
The health needs of the population are currently unmet 
and far exceeding the existing capability, awareness, and 
response of the Venezuelan governmental institutions 
[29]. Once considered one of the richest countries in 
Latin America due to its oil reserves and mineral 
deposits, as well as tourist attractions, Venezuelan 
development indexes have dropped producing a major 
humanitarian crisis with catastrophic health implications 
including increased childhood mortality (63% increased 
only in 6 years from 2012-2018) [15]. A major health 
crisis has erupted resulting from a major breakdown in 
the provision of health services due to insufficient 
medical supplies and medications, the exodus of 
specialized physicians, poorly paid healthcare providers, 
and the fallout of healthcare institutions and 
infrastructure [29]. Also, in this context, natural disasters 
can be aggravated due to inertia or human wrongdoing. 
No development is possible within this 
anthropogenic crisis, and it would be very difficult for 
Venezuela to reach the Sustainable Development Goals 
(SDG) in 2030, even if the group currently sitting in 
office left and the country transitioned to the interim 
government now recognized by most Western 
democracies. The SDGs are the blueprint for achieving a 
better and more sustainable future for all according to the 
United Nations Organization (UN) [30]. They address 
the global challenges we face, including those related to 
poverty, inequality, climate, environmental degradation, 
prosperity, and peace and justice.  
For Venezuela, the time seems to be over. This 
nation is suffering consequences of two disruptive 
anthropic events, the first at a local scale, given by two 
decades of negligence in the management of resources, 
and the other, a global scale menace, related to effects of 
global warming due to human activity over the same time 
[31, 32]. Every day the crisis is happening without 
solutions, with undeniable consequences of the climate 
change that will be easier to notice every year, and the 
window time to repair Venezuela will be smaller year 
after year.   
The SDGs interconnect, and in order to leave no one 
behind, it is important that we achieve each of them and 
target on time. There are 17 SDGs with 169 targets that 
all 191 United Nations Member States have agreed to try 
to achieve by the year 2030, including Venezuela. Health 
has a central place in SDG 3: Ensure healthy lives and 
promote well-being for all at all ages, underpinned by 13 
targets that cover a wide spectrum of the World Health 
Organization (WHO) work [33]. However, almost all of 
the other 16 goals also related to health or will contribute 
to it, directly or indirectly. The new agenda, which builds 
on the Millennium Development Goals, aims to be 
relevant to all countries and focuses on improving equity 
to meet the needs of women, children and the poorest, 
most disadvantaged people. For the first time, extreme 
poverty is higher than non-extreme poverty; more than 
half of the country’s population does not have enough 
income to meet their basic food needs (Figure 1) [17, 21]. 
There is no adequate public health or policy plan that 
guide the programs to deal with significant health issues 
and diseases, as is the case in the neighboring country 
Colombia (Figure 2), which is advancing with its 
National Plan of Public Health 2012-2021 of the 
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Ministry of Health, which especially considers 
communicable diseases [34]. 
 
Infectious Diseases 
Malaria 
Historically, Venezuela was a regional leader in the 
control of vaccine-preventable diseases and tropical 
diseases.  For example, before 1936, Venezuela had the 
highest number of human malaria cases in Latin 
America, but due to major government-led public health 
initiatives, achieved malaria eradication in over 80% of 
endemic areas by 1960 [7, 8, 13, 35-42]. In the 1980s and 
extending into the 1990s there was a resurgence of 
malaria cases, but major control efforts were able to 
reach control levels of malaria transmission in most 
districts. Malaria was endemic to >600,000 km2 (65.5%) 
of this country (from a total of 916,445), consequently 
leading to major population decreases from malaria 
deaths during this same period [43]. Additionally, the 
problem of resistant malaria is added in some states of 
Venezuela such as Bolivar [39]. Regretfully, in the last 
two decades, despite major scientific advances in the 
prevention, diagnosis, and treatment of malaria [44-46], 
there is an ongoing major malaria epidemic of 
unprecedented magnitude [14, 39]. Indeed, Venezuela 
has become the epicenter of an increasing number of 
malaria cases spreading to other countries including 
Colombia (Figure 2) and Brazil. In fact, in Colombia, 
more than 95% of imported cases of malaria are from 
Venezuela [7]. A lack of national vector-control efforts, 
insufficient supply of antimalarial medications, and poor 
access to healthcare fuels the burden of malaria in 
Venezuela. 
 
Other tropical diseases 
A similar situation takes place in many other major 
neglected tropical infections such as Chagas disease [47, 
48], leishmaniasis [49-52], and tuberculosis (TB) [5, 53]. 
Once under control, today we see inoperative control 
programs and recurrent outbreaks in Venezuela. 
Trypanosoma cruzi infection has resurfaced as a 
pathogen causing important urban outbreaks, including 
those affecting the Venezuelan capital [48, 54, 55], but 
also in border areas with Colombia, including some fatal 
acute cases linked to oral transmission [47]. The 
urbanization-spreading phenomena of leishmaniasis 
have been recently reported [49]. In Barquisimeto and 
Cabudare, Lara state, this has been recently reported 
[50]. Previously, the flux of imported cases of 
leishmaniasis was from Colombia to Venezuela, 
following the migration from the first to the second in the 
1980s and 1990s [56]. Currently, the opposite is true: 
according to the National Institute of Health of Colombia 
(www.ins.gov.co), during 2017 there were at least 43 
imported cases of cutaneous leishmaniasis with 58% of 
them from Venezuela. In 2018, this number increased to 
56, and 87.5% of them were from Venezuela (Table 1) 
[57]. A similar situation occurs with TB. In 2017, 65% 
of the 84 imported cases were from Venezuela. However, 
this number tripled by 2018 [57]. This number is 
expected to increase by 2019 since, by early March 2019, 
there are already 14 imported cases of TB from 
Venezuela (Table 1) [58]. 
 
Figure 2. Venezuelan migrants in Colombia.  
A. People were making long lines for free meal centers in Cucuta, 
Norte de Santander (March 2019). B. Homeless or street people are 
asking for money in Pereira, Risaralda (March 2019). C. Improvised 
informal refugee camps in north Cali, Valle del Cauca (November 
2018). The authors of this review article personally took all these 
photographs. 
 
 
Today Venezuela is facing a complex group of 
factors similar to what happened in some former Soviet 
republics related to the expansion of multidrug-resistant 
TB (MDR-TB) in Eastern Europe [59]. Given the current 
migration crisis, today this would be possible for the 
Americas. Then, in countries such as Colombia, MDR-
TB surveillance is necessary [60].  
Recent studies have suggested that conventional 
methods are not enough, and new approaches are 
required [61, 62]. Also, Venezuelan migrants are moving 
to countries, such as Peru with a high prevalence of 
MDR-TB, even extensively drug-resistant TB (XDR-
TB) with additional adverse social conditions in such 
countries [63]. 
 
Arboviral diseases 
At this time, it is difficult to determine the overall 
impact of arboviral epidemics in Venezuela since there 
is limited government published epidemiological 
information and insufficient and ineffective surveillance 
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programs. Alarmingly, morbidity and mortality derived 
from dengue and another arbovirosis on those most 
susceptible to deleterious outcomes, like children and 
pregnant patients, are also unknown and difficult to 
estimate [14, 64-66].  
Dengue epidemics have even spilled over to distant 
parts of the world such as the Madeira islands of Portugal 
[67] since 2012 [68-71]. The National Institute of Health 
of Colombia (www.ins.gov.co) reported that during 2017 
there were at least 49 imported cases of dengue and 31% 
of them from Venezuela. However, by 2018, more than 
350 cases were imported cases from Venezuela with 3 
cases of severe dengue (Table 1) [57]. So far, in early 
2019, there are already 38 imported cases reported of 
which 29 (76%) are imported from Venezuela (Table 1) 
[58].  
 
Table 1. Selected imported infectious diseases from 
Venezuela reported by the National Institute of Health 
(www.ins.gov.co) of Colombia, 2017-2019. 
Imported Infectious Diseases 
Years 
2017 2018 2019* 
Leishmaniasis N 43 56 N/A 
 n Venezuela 25 49 N/A 
 % 58.1 87.5 N/A 
Tuberculosis N 84 220 N/A 
 n Venezuela 55 200 N/A 
 % 65.5 90.9 N/A 
Dengue N 49 383 38 
 n Venezuela 15 355 29 
 % 30.6 92.7 76.3 
 % Severe N/A 3.1 N/A 
Pertussis N 8 46 5 
 n Venezuela 7 43 5 
 % 87.5 93.5 100.0 
Varicella N 63 116 5 
 n Venezuela 32 100 4 
  % 50.8 86.2 80.0 
*Till March 10, 2019. N/A, not available. 
 
In recent years, the bordering Colombian 
departments of Norte de Santander (Figure 2), Cesar, and 
La Guajira have experienced dengue and other arboviral 
epidemics with important potential implications of 
becoming epicenters of new upcoming epidemics from 
imported Venezuelan cases [72-76]. In addition, a recent 
study undertaken in Zulia state revealed a deep spatial 
temporal analysis of dengue fever using a generalized 
additive mixed model with a set of climatic and non-
climatic factors [77]. In this regard, the authors 
concluded that an urgent sanitary intervention is needed 
at a national scale, including georeferenced variables of 
dengue fever and relevant explanatory factors. 
Furthermore, the improvement on living conditions by 
ensuring water supply, electricity and garbage collection 
are essential to mitigate the sanitary chaos in accordance 
with those findings. Even more, the spillover to other 
distant countries of the region is possible, as occurred in 
Argentina in 2009-2010, with the detection of dengue 
serotype 1 in Buenos Aires, which was inferred mainly 
from Venezuela [78].  
In Latin America, the epidemic of chikungunya of 
2014 and Zika virus epidemic of 2015 reached 
Venezuelan territory [14]. The attack rate of 
chikungunya (CHIKV) at a national level was estimated 
between 7% and 14%, and the observed attack rate 
reached 40–50% of major populated urban areas. In 
2014, Venezuela reported to the Pan American Health 
Organization (PAHO) a total of 30,405 cases of 
chikungunya (incidence of 112 per 100,000 population), 
16,000 cases in 2015, 4,000 in 2016, and only 341 by 
2017 [14, 79]. The first description of atypical and 
fulminant cases of chikungunya in Latin America 
occurred in Venezuela.  Many of these patients 
experience a life-threatening, aggressive clinical course, 
with rapid deterioration and death due to multi-organ 
dysfunction syndrome [80, 81]. Imported cases of 
Chikungunya from Venezuela occurred in Italy [82] and 
Spain [83, 84] during 2015 and 2016. There are, 
however, no systematic studies to assess the incidence of 
post-CHIKV chronic disease (pCHIKV-CD) in 
Venezuela [85]. However, some estimates suggest that 
between 16,686 and 18,556 patients developed 
pCHIKV-CD in 2014 [85]. If we assume the rates of 
progression to pCHIKV-CD based on systematic reviews 
of pCHIKV-CD of global studies [86] approximately 
40% of cases reported in Venezuela during the epidemic 
of CHIKV likely developed pCHIKV-CD (between 
20,400 and 40,235 cases).  
Additionally, there is no information available 
regarding congenital infection associated with CHIKV in 
Venezuela, despite its description in neighboring 
countries [87-89], including Colombia [90], even when 
this is expected to have occurred in the country. 
Since 2015 health conditions of Venezuela, together 
with the tropical proliferation of different types of Aedes 
(aegypti and albopictus), suggest the arrival to this 
country of Zika virus. PAHO urges Latin American 
countries to take measures to prevent the Zika virus entry 
and advises that these measures must be designed to 
detect the introduction of Zika in an area, track its spread 
and actively monitor the disease.  
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In Venezuela where endemicity is high for other 
arboviruses such as dengue and chikungunya, the high 
incidence of cases due to those viral agents reflects 
weakened and poorly timed insensitive monitoring 
systems [91]. 
In January 2016, the Zika virus epidemic struck 
Venezuela at the same time as a rise in dengue virus 
transmission took place [14]. The incidence estimates of 
symptomatic cases during the peak of the epidemic (the 
first eight weeks of 2016) was 2,124 cases per 100,000 
population [14]. According to PAHO, a total 67,294 of 
Zika cases in Venezuela occurred between 2015 and 
early 2019 (61,691 during 2016 for an incidence rate of 
195.73 cases/100,000 population) [92]. There were 
limited research efforts in describing the epidemiology 
of Zika virus in Venezuela compared to neighboring 
countries (e.g., Brazil and Colombia) for the same period 
[93-100]. Zika virus epidemics in Venezuela led to 
imported cases to other countries such as the United 
States [101], and China [102]. In general terms, given the 
special attraction of Venezuela as a tourist destination, 
imported cases of infectious diseases even in distant 
countries have been reported in the last decades [103]. 
There are only a limited number of reports of Congenital 
Zika syndrome (CZS) in Venezuela [93, 94, 104, 105]. 
The Mayaro virus is an arbovirus that has once again 
become part of the epidemiological picture in Venezuela, 
together with Zika, chikungunya and dengue viruses. In 
2016, the virus caused an epidemiological alert in several 
countries of Latin America after the Zika emergency 
[106]. In December 2018, due to the crisis in the health 
sector in Venezuela and the lack of official information 
on the cases, several organizations brought attention to a 
series of cases in Venezuela of a new disease that is 
similar to dengue and chikungunya fever in its early 
stage, (but without confirmatory laboratory results). 
Along with the history of cases of Mayaro fever in Brazil, 
there is a suspicion of a new incursion of Mayaro virus 
in the country. This shows, again, important failures in 
the surveillance system, which has lost its diagnostic and 
proactive characteristics, which contributes not only to 
the spread of diseases such as that caused by Mayaro 
virus but also of other documented diseases as malaria 
[13, 107]. 
In Venezuela, other risks of arboviral diseases are 
imminent and uncertain; for example, Oropouche virus 
is the aetiological agent of Oropouche fever, a zoonotic 
disease mainly transmitted by midges of the species 
Culicoides paraensis. Although the virus was discovered 
in 1955, more attention has been given recently to both 
the virus and the disease due to outbreaks of Oropouche 
fever in different areas of Brazil and Peru. Serological 
studies in human and wild mammals have also found 
Oropouche virus in Argentina, Bolivia, Colombia, and 
Ecuador [108]. Given the wide geographic distribution 
of the competent vector in America, there is a 
considerable risk of introduction of the Oropouche virus 
in countries with ecological characteristics suitable for 
its transmission, such as Venezuela. However, the 
similarity with other arboviral diseases and the 
insufficient and ineffective surveillance programs makes 
its real incidence unknown in this country [109]. 
 
Vaccine-preventable diseases (VPDs) 
Decrease and lack of vaccination for most of the 
routine vaccine-preventable diseases (VPDs) are a matter 
of concern in Venezuela and beyond. Most authors 
concord in that there is a general resurgence of VPDs in 
the country [5, 8, 11]. There are some of them in 
epidemic situation persisting for over four years [110], 
e.g., diphtheria, affecting not only children in urban but 
also in rural settings, including Amerindian populations 
[111]. Measles, mumps, pertussis, tetanus, also, have 
been reported on raise [5, 8, 11]. Specially measles, 
which until March 2019 counts with 9,116 suspected 
cases (1,307 in 2017 and 7,809 in 2018), including 6,202 
confirmed cases (727 in 2017 and 5,475 in 2018) [112]. 
It is also worthy of mentioning that there were 76 deaths 
reported: 2 in 2017 and 74 in 2018. For diphtheria, the 
outbreak began in July 2016 and remains ongoing. Since 
the beginning of the outbreak until EW 8 of 2019, a total 
of 2,726 suspected cases were reported (324 cases in 
2016, 1,040 in 2017, 1,198 in 2018, and 164 in 2019); of 
these, 1,612 were confirmed (528 by laboratory and 
1,084 by clinical criteria or epidemiological link), with 
280 deaths reported (17 in 2016, 103 in 2017, 150 in 
2018, and 10 in 2019), until March 2019 [110]. As 
expected, this is impacting other countries of the region.  
In Brazil, the reintroduction of the measles virus in 
Manaus, and probably other areas, is likely related to the 
current outbreak in Venezuela from the recent decline in 
measles vaccine coverage [113]. In Colombia, during 
2018, there were 204 cases of measles, 27% imported 
from Venezuela (22 cases from Caracas) and 58% related 
to imported cases (autochthonous transmission) [114]. In 
areas with appropriate measles vaccine coverage, such as 
was the case of Santa Rosa de Cabal, a municipality of 
Risaralda, the occurrence of an imported Venezuelan 
case did not evolve into an outbreak of autochthonous 
cases. However, in San Onofre, Sucre, from 3 imported 
cases from Venezuela, there were four additional 
autochthonous cases, as the vaccine coverage was not 
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appropriate [115]. By the 51° epidemiological week of 
2018, there were in total 54 imported cases and 106 cases 
related to the imported cases, including 16 imported 
cases in Cucuta and 10 cases related to them [115]. Also, 
pertussis is increasing among migrants, in 2017, there 
were 8 cases, 7 (88%) from Venezuela and in 2018, 46 
with 43 (94%) from that country (Table 1) [57]. This 
would show a sentinel event of the real situation in 
Venezuela that has been underreported since between 
2012 and 2016, only 17 cases of pertussis were notified 
to PAHO/WHO [8]. For the same period, also 290 cases 
of mumps were reported to PAHO/WHO [8]. Varicella, 
another VPD, is being increasingly reported among 
migrants, from 63 cases in 2017 (51% in Venezuelans) 
to 116 in 2018 (86% in Venezuelans) (Table 1) [57]. In 
2015, as of September 12th (week 36), 41,294 
accumulated cases of varicella were reported in the 
country. The incidence rate for 2015 was estimated in 
171.36 cases per 100,000 inhabitants. The incidence rate 
for 2014 was 146.17 cases per 100,000 inhabitants [116]. 
In the case of mumps, this is also increasing among 
Venezuelan migrants, from 4 cases in 2017 to 12 in 2018 
(Table 1) [57]. In Ecuador, the same genotype that 
originated in Venezuela was detected, for a total of 11 
imported cases of the 19 cases reported in 2018 [117]. 
 
Other Tropical and Infectious Diseases 
Other conditions reported to have increased among 
migrants from Venezuela in Colombia during 2018 and 
2019 include snakebites [118], injuries by rabies-
potentially transmitting animals, respiratory tract 
infections, hepatitis A (from 19 cases in 2017 to 171 in 
2018), bacterial meningitis, congenital syphilis (from 19 
cases in 2017 to 108 in 2018), gestational syphilis (from 
38 cases in 2017 to 288 in 2018), conditions that were 
reported to be worsening in the last decades among 
pregnant women and children in Venezuela with 
multiple clinical consequences [119-123]. Other 
increases have been reported for HIV and other viral 
diseases [57, 58]. For HIV, more than 80% of imported 
cases in Colombia proceed from Venezuela affecting 
Norte de Santander (capital Cucuta) [9] particularly. In 
general terms, Norte de Santander is under warning, 
given the fact most communicable diseases are 
increasing from 2017 to 2018 and probably 2019 [57, 
58].  
In relation to HIV, the poor condition of the health 
system that Venezuela suffers, from not receiving 
medicine therefore also migrate in search of a treatment, 
this can take a long time, involuntary withdrawals, which 
can lead to the development of resistant strains and 
progression of disease, opportunistic infections, higher 
possibility of hospitalization and consumption of major 
hospital expenses [5, 9, 10, 53, 62, 119, 124-126]. 
According to studies conducted in the first decade of 
this century, the seroprevalence of Hepatitis C Virus 
(HCV) in the general population of Venezuela is 
approximately 1.5% [127], however, there is a lot of 
under-reporting of this viral infection [128], which 
probably it has been increased in recent years due to a 
major shortage of reagents for diagnosis [3]. Based on 
the above, the 6 million of crisis-related Venezuelan 
immigrants are taking to the host countries, at least 
90,000 new cases of HCV infection, which obviously 
will have a major impact on the dynamics of HCV 
transmission in those countries. 
 
Non-Communicable Diseases 
The health status concerning non-communicable 
chronic diseases in Venezuela is no different from 
communicable infectious diseases. With only 15% of the 
essential medications available and only 10% of 
chemotherapy and biologicals needed to treat 
oncological patients [129], national oncology centers do 
not guarantee chemotherapy for some 140,000 people 
with a diagnosis of cancer. Of 25 radiotherapy units, only 
four are operational. According to the Venezuelan Health 
Alliance, surgical oncological interventions occur in less 
than half of patients needing these procedures. It is 
limited or a lack of availability of screening 
mammography or CT scanning imaging [130]. Facing 
scarcity of essential medication and broken-down 
medical equipment, women diagnosed with breast cancer 
in Venezuela resort to more radical means of treatment 
[131]. Treatments for breast cancer are no longer 
available in public hospitals. Even more, according to the 
National Institute of Health of Colombia 
(www.ins.gov.co), during 2017 there were at least 30 
cases of breast and cervix cancer diagnosed among 
recently emigrated Venezuelans and 82 cases in 2018 
(Table 2) [57]. By early 2019, there are five new cases 
reported among Venezuelan migrants (Table 2) [58]. 
The Venezuelan crisis has touched every area of the 
health system. Pathology national reference center 
(Instituto Anatomopatológico Dr. José O’Daly), in 
Caracas, received around 18,000-20,000 biopsies per 
year, in addition, to being the first training center for 
specialists, has started to decline its activities since 2014, 
afterward stopped definitely at the end of 2017. The 
insecurity to which staff and patients were subjected 
continuously besides the inability to acquire supplies, 
resulted in the halting of activity. The cancer diagnosis it 
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has been reduced into the few private centers that have 
managed to maintain the activity but with retail prices are 
impossible to pay for the general populations, especially 
because many of them have been obliged to request 
payments in foreign currency. We must remember, the 
average monthly income of the Venezuelan worker is $6, 
biopsies prices can range from $25 (for example, skin 
punch) to $300 (simple mastectomy) [132]. 
Since 2016, more than 300,000 Venezuelans with 
chronic medical diseases including transplant patients, or 
those suffering hemophilia, cancer, Parkinson's disease, 
or multiple sclerosis have not received necessary medical 
treatments [130]. 
  
Table 2. Selected indicators of sexual and reproductive health 
and childhood health indicators among Venezuelan migrants 
reported by the National Institute of Health (www.ins.gov.co) 
of Colombia, 2017-2019. 
Sexual and Reproductive Health Years 
and Childhood Health Indicators 2017 2018 2019* 
Breast cancer and cervix N 30 82 5 
n Venezuela 26 80 5 
% 86.7 97.6 100.0 
Extreme maternal 
morbidity 
N 60 349 39 
n Venezuela 54 340 38 
% 90.0 97.4 97.4 
Perinatal and late neonatal 
deaths 
N 55 245 21 
n Venezuela 48 236 21 
% 87.3 96.3 100.0 
Acute undernutrition in 
children <5 y-old 
N 73 425 49 
n Venezuela 64 418 48 
% 87.7 98.4 98.0 
Deaths due to 
undernutrition 
N 3 11 0 
n Venezuela 3 11 0 
% 100.0 100.0 0.0 
CFR% 4.7 2.6 0.0 
Low birth weight N 65 257 29 
n Venezuela 63 254 29 
% 96.9 98.8 100.0 
Birth defects N 41 103 0 
n Venezuela 35 97 0 
% 85.4 94.2 0.0 
*Till March 10, 2019. CFR%, case fatality rate (%). 
 
The situation of patients with terminal organ failure 
who are candidates for transplantation and those who 
have already been transplanted is critical; among the 
reasons are the increase in the number of people on the 
waiting list for transplantation due to the paralysis of 
organ transplant activity with deceased donor and the 
drastic decrease in transplants with living donors due to 
the lack of availability in the country of induction 
immunosuppressive treatment, which is mandatory at the 
time of performing the transplant, the extremely 
precarious conditions because of shortages, equipment 
paralysis and continuous electricity and water supply 
failures in hospitals and public health centers that house 
transplant centers, the marked shortage of 
immunosuppressants and its consequences in terms of 
graft and patient survival, the shortage of reagents to 
measure levels of immunosuppressants such as 
tacrolimus and cyclosporine, hindering the appropriate 
control of post-transplant patients [133].  
As a result, many transplant patients will 
inexcusably lose their grafts due to rejection, in addition, 
to become sensitized after exposure to non-self-human 
leukocyte antigen (HLA) experiencing permanent 
anguish, and in many cases, they will lose their lives.  
Performing transplantation in highly sensitized 
receptors represents a challenge for any transplant 
program and the patients are forced to stay on transplant 
waiting lists for many years and ultimately may never 
find a donor, and they may never receive a transplant due 
to removal from or death while on the waiting list. 
Currently, it is estimated that up to 35% of patients who 
are on the waiting list for a transplant are sensitized, but 
in Venezuela, this number will increase progressively. 
This situation limits patients’ access to transplant as well 
as the success of the transplant [134]. Desensitization 
protocols have shown acceptable short-term recipient 
and graft outcomes, but increased rates of acute and long-
term antibody-mediated rejection and decreased overall 
allograft survival that has raised concerns about the long-
term success, so sensitization is a significant barrier to 
successful transplantation [135]. On the other hand, 
desensitization protocols have been associated with an 
increased risk of BK virus (polyomavirus family) 
nephropathy [136] and they are costly, demand a long 
time, and most importantly, can produce many severe 
complications including hematoma, pneumothorax, 
catheter infection, anaphylactoid reaction, coagulopathy, 
hypotensive episodes, transmission of viral infection, 
and generalized infections of immunocompromised 
patients [17]. 
The Venezuelan Society of Nephrology (VSN-SVN) 
has documented the profound lack of resources to treat 
patients in dialysis units, the absolute absence of 
materials for peritoneal dialysis programs, which have 
been closed to admissions of new patient placing them in 
great risk.  
The National Transplant Organization of Venezuela 
(ONTV) in partnership with the Venezuelan Nephrology 
Society, conducted an epidemiological study in April 
2018, through the survey technique to gather information 
to more accurately characterize the scope and 
consequences of availability of immunosuppressant in 
the transplanted population or with renal pathology 
treated with this type of medication and the situation of 
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those affected by renal pathologies that receive renal 
replacement therapy with dialysis and transplantation. 
Over 95% of the patients reported difficulty in obtaining 
immunosuppressants and the number of transplants fell 
by 80% between 2012 and 2017 [137].  
In June 2017, the organ and tissue procurement 
system suspended procurement and allocation of organs, 
and so far, they have not resumed. Medical 
complications have been on the rise with a report of 42% 
in the year 2017.  
The respondents reported a total of 366 medical 
complications, increased hospitalizations, the 
appearance of renal failure, rejection, graft loss, and 26 
deaths and 54 dialysis admissions were reported due to 
renal graft loss.  
The main reasons for the suspension of the transplant 
activity were the lack of immunosuppressant (96%), 
failures in the infrastructure (72%) and failures in the 
support services (60%) [137]. 
The number of individuals with end-stage kidney 
disease (ESRD) in 2015, in Venezuela, was 595 patients 
per million population under renal replacement therapies 
(RRTs) but no recent data is available [137].  
Recent news indicated that apparently the 
Venezuelan Social Security Institute ignored the needs 
for equipment and dialysis therapies leading to 
approximately 5,000 patients with ESRD died between 
2018 and 2019 [136]. 
There are reports of the impact on the quality of life 
and wellbeing of most of the Venezuelan population, 
which has worsened in the last five years. Occupational 
Safety and Health (OSH) is not a priority for firms in the 
middle of the economic emergency with a general 
deterioration of daily life [17].  
Despite the relevance of this problem, research on 
the subject is very limited. Recent and pertinent data is 
needed to properly identify and measure the risks and 
negative consequences that workers and families are 
exposed to by the ongoing crisis [17].  
Substantial governmental actions are needed in the 
immediate future to improve occupational safety and 
health of Venezuelan workers but, as expected with the 
current government, this is not a priority for health and 
labor authorities [24].  
Also, a probably not properly assessed, suicide 
intention and gender violence, are part of mental 
consequences that are on the rise among migrants from 
Venezuela [57, 58]. Other problems, already reported in 
a significantly higher prevalence among internally 
displaced populations of Colombia, such as post-
traumatic stress disorder and alcoholism, should also be 
studied on Venezuelan migrant and refugee populations 
[138, 139]. 
 
The Situation as Impediment to Achieve the 
Sustainable Development Goals 
As individually analyzed, or compared with 
neighbor countries, Venezuela is in reverse for multiple 
SDG indicators (targets), as observed in recent data of 
WHO and its SDG statistics derived from the last World 
Health Statistics report for 2018 [140]. A comparison 
between Colombia and Brazil with Venezuela is 
presented in Table 3. Venezuela in 20 targets is worse 
than Brazil and Colombia: Life expectancy at birth, 
current health expenditure (CHE) as percentage of gross 
domestic product (GDP), maternal mortality ratio, under-
five mortality rate, neonatal mortality rate, malaria 
incidence, Hepatitis B surface antigen (HBsAg) 
prevalence among children under 5 years, probability of 
dying from any of CVD, cancer, diabetes, CRD between 
age 30 and exact age 70, road traffic mortality rate, 
mortality rate attributed to exposure to unsafe WASH 
services, diphtheria-tetanus-pertussis (DTP3) 
immunization coverage among 1-year-olds, measles-
containing-vaccine second-dose (MCV2) immunization 
coverage by the nationally recommended age, 
pneumococcal conjugate third dose (PCV3) 
immunization coverage  among 1-year old’s, domestic 
general government health expenditure (GGHE-D) as 
percentage of general government expenditure (GGE), 
prevalence of stunting in children under five, prevalence 
of wasting in children under five, proportion of 
population using safely managed sanitation services, 
mortality rate due to homicide and completeness of 
cause-of-death data (Table 3). 
 
Maternal and Child Health in Venezuelan Migrants 
to Colombia 
Pregnant women are migrating due to the country’s 
conditions. According to the National Institute of Health 
of Colombia, in 2017, there were 649 newborns in which 
the mother was migrating from Venezuela, increasing to 
3,048 in 2018 (873% increase). Most were born in Norte 
de Santander, but also in La Guajira, Bogota, Bolivar and 
Arauca [57]. In 2017, a total of 2,320 people from 
Venezuela crossed the border requiring medical attention 
in Colombia, 23.9% were less ten years old. In 2018, that 
figure increased to 6,172, with 28.9% below ten years of 
age [57]. In 2019, 558 new people were reported on those 
conditions, 27.1% children less than ten years of age 
[58]. From the total of people diagnosed by the 
healthcare system of Colombia in 2018 proceeding from 
Suárez et al –Anthropogenic Disasters and Infectious Diseases in the Venezuelan Crisis 2019 
83 
 
 
Rev Panam Enf Inf 2018; 1(2):73-93. 
Venezuela, 19.8% were housewives. In 2017, 60 
pregnant women with extreme maternal morbidity from 
other countries arrived in Colombia, 90% of Venezuela, 
but in 2018 were 349 with 97.4% from that country 
(Table 2) [57]. In 2019, so far, 39 women have been 
diagnosed, 38 (97.4%) from Venezuela (Table 2) [58].  
Unfortunately, WHO data is consistent with the 
figures of migrant cases in Colombia from Venezuela for 
maternal mortality. In 2017, seven deaths were reported 
from migrant pregnant women (all from Venezuela). In 
2018, this increased to 15 (all from Venezuela). For 
2019, three additional deaths have been reported [57, 58]. 
For perinatal and late neonatal mortality, figures are 
high, with 55 deaths in 2017 from migrants, 87.3% from 
Venezuela, increasing to 245 in 2018, with 96.3% from 
Venezuela (Table 2) [57]. 
In 2019, there are 21 additional deaths, all from 
Venezuelan migrants (Table 2) [58]. From 2012 to 2016, 
infant deaths in Venezuela increased by 63% and 
maternal mortality more than double [5]. 
Children health, as seen in these data, is precarious 
in Venezuela [15, 16]. There is no longer an appropriate 
coverage of vaccines. Moreover, vaccine-preventable 
diseases are raising with no control and spilling over to 
other countries in the region [5, 8, 11, 22, 28, 53, 111, 
141]. Besides all the above, the anti-vaccination 
movement in the last time has increased the risk of 
diseases already controlled in our region, mainly 
measles. However, others such as tetanus and polio could 
be relevant if the mentioned factors are not controlled 
[142]. In this context, Amerindians of Venezuela have 
been significantly affected by this situation, suffering 
from multiple VPDs, especially measles and diphtheria 
[8, 111]. Among Amerindians, recently also trachoma, a 
neglected tropical disease, has also been reported in the 
southern border area with Brazil [12]. A cluster of five 
migrant Amerindian children from Venezuela to Brazil 
(Belen, Para state) were recently reported dead due to 
suspected pneumonia, probably influenza [143]. 
 
Malnutrition Cases 
Children in Venezuela, but also the adult population 
are suffering from food insecurity and malnutrition. As 
Venezuela's economic and political crises continue to 
evolve, hyperinflation, declining food production and 
food shortages are contributing to the deterioration of the 
food and nutrition situation [23]. The prevalence of 
undernutrition has been increasing from 3.6% (2010-
2012) to 11.7% (2015-2017) [23]. In 2018, there were at 
least 540 pediatric hospital admissions with acute 
malnutrition across the states of Venezuela, 77% of 
them, in Delta Amacuro. Of them, 202 died, 69% in 
Delta Amacuro [23]. This is also being reflected in 
migrants from Venezuela in Colombia, in 2017 there 
were 73 cases of children <5 years-old arriving from 
other countries diagnosed with acute undernutrition, 
88% from Venezuela. In 2018, this was 5.8 times higher 
(425), with 98% from Venezuela. In 2019, there have 
been 49 with 48 (98%) from Venezuela (Table 2) [57, 
58]. In 2017-2018 there were 14 deaths due to 
undernutrition in Venezuelan children arriving and being 
diagnosed in Colombia (CFR% 2.3) (Table 2) [57]. Even 
more, low birthweight has also been reported 
increasingly among migrant newborns arriving from 
Venezuela. In 2017 there were 65 newborns with low 
birthweight, 97% from Venezuela, in 2018, 257 with 
99% from Venezuela and in 2019, 29, all from Venezuela 
(Table 2) [57, 58].  
Also, birth defects, are increasing among 
Venezuelan migrants. In 2017, there were 41 birth 
defects among migrant newborn, 85% were from 
Venezuela; in 2018, the figure increased to 103, with 
94% from Venezuela (Table 2) [57, 58]. Food security in 
Venezuela is also a threat by problems of water supply 
and sanitation that threats the previous advances in the 
control of soil-transmitted helminthiasis and other food-
borne pathogens [144-147]. 
 
Humanitarian crisis 
Very recent conservative estimates indicate that 
Venezuela is in the throes of a humanitarian crisis. Infant 
mortality rate reached 21.1 deaths per 1,000 live births 
(90% CI −17.8 to 24.3) in 2016, almost 1.4 times the rate 
of 2008 (15.0, −14.0 to 16.1) [15]. The increase in infant 
mortality rate in 2016 compared with 2008 takes the 
country back to the level observed at the end of the 
1990s, wiping out 18 years of expected progress, and 
leaves the Venezuelan Government far from achieving 
the target of nine deaths per 1000 livebirths stated in the 
UN Millennium Development Goals [15]. 
Venezuela has endured an unprecedented and 
worsening humanitarian crisis and anthropogenic 
disaster that has forced more than 4 million people to flee 
the country over the past two years alone. Countries like 
Colombia, Peru, and Ecuador have declared a State of 
Emergency given the Influx of Venezuelan Refugees 
seeking to enter their territories [148].  
All of the above health indicators illustrate that the 
resulting public health and health services crisis in 
Venezuela is appalling and requires urgent attention. 
Health outcomes are approaching catastrophic levels [4, 
29, 53]. 
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Table 3. Health-related SDG statistics in Brazil, Colombia, and Venezuela, based on WHO health statistics [140]. 
SDG Indicator Source Sex Year Brazil Colombia 
Venezuela 
(Bolivarian 
Republic of)  
Total population a (000s) Comparable 
estimates 
 
2016 207 653 48 653 31 568 
 
Life expectancy at birth b,c (years) Comparable 
estimates 
Male 2016 71.4 71.5 69.5  
Female 78.9 78.8 79.0  
Both 
sexes 
75.1 75.1 74.1 
 
Healthy life expectancy at birth b,c (years) Comparable 
estimates 
 
2016 66.0 67.1 66.1 
 
Current health expenditure (CHE) per 
capita d (US$) 
Comparable 
estimates 
 
2015 780 374 973 
 
Current health expenditure (CHE) as 
percentage of gross domestic product 
(GDP) d (%) 
Comparable 
estimates 
 
2015 8.9 6.2 3.2 
3.1 Maternal mortality ratio e (per 100 000 
live births) 
Comparable 
estimates 
 
2015 44 64 95 
Proportion of births attended by skilled 
health personnel f (%) 
Primary data 
 
2007–
2017 
99 96 96 
     
ag 
 
ag 
3.2 Under-five mortality rate g (per 1000 live 
births) 
Comparable 
estimates 
 
2016 15.1 15.3 16.3 
Neonatal mortality rate g (per 1000 live 
births) 
Comparable 
estimates 
 
2016 7.8 8.5 10.3 
3.3 New HIV infections h (per 1000 
uninfected population) 
Comparable 
estimates 
 
2016 0.24 0.12 0.21 
Tuberculosis incidence i (per 100 000 
population) 
Comparable 
estimates 
 
2016 42 32 32 
Malaria incidence j (per 1000 population 
at risk) 
Comparable 
estimates 
 
2016 6.7 17.2 44.7 
Hepatitis B surface antigen (HBsAg) 
prevalence among children under five 
years (%) k (%) 
Comparable 
estimates 
 
2015 0.07 0.21 0.62 
Reported number of people requiring 
interventions against NTDs l 
Other data 
 
2016 10 461 013 3 761 361 282 294 
3.4 Probability of dying from any of CVD, 
cancer, diabetes, CRD between age 30 
and exact age 70 c,m (%) 
Comparable 
estimates 
 
2016 16.6 15.8 18.1 
Suicide mortality rate c,m (per 100 000 
population) 
Comparable 
estimates 
 
2016 6.5 7.2 3.7 
 
Total alcohol per capita (>= 15 years of 
age) consumption n (litres of pure 
alcohol) 
Comparable 
estimates 
 
2016 7.8 5.8 5.6 
3.6 Road traffic mortality rate o (per 100 000 
population) 
Comparable 
estimates 
 
2013 23.4 16.8 45.1 
3.7 Proportion of married or in-union women 
of reproductive age who have their need 
for family planning satisfied with modern 
methods p (%) 
Primary data 
 
2007–
2017 
89.3 86.5 - 
Adolescent birth rate q (per 1000 women 
aged 15-19 years) 
Primary data 
 
2007–
2016 
60.8 71.6 - 
3.8 UHC service coverage index r Comparable 
estimates 
 
2015 77 76 73 
Population with household expenditures 
on health > 10% of total household 
expenditure or income s (%) 
Primary data 
 
2007-
2015 
25.6 16.9 - 
Population with household expenditures 
on health > 25% of total household 
expenditure or income s (%) 
Primary data 
 
2007-
2015 
3.5 2.8 - 
3.9 Age-standardized mortality rate 
attributed to household and ambient air 
pollution c,t  (per 100 000 population) 
Comparable 
estimates 
 
2016 29.9 37.0 34.6 
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SDG Indicator Source Sex Year Brazil Colombia 
Venezuela 
(Bolivarian 
Republic of) 
Mortality rate attributed to exposure to 
unsafe WASH services c,t (per 100 000 
population) 
Comparable 
estimates 
 
2016 1.0 0.8 1.4 
Mortality rate from unintentional 
poisoning c,m (per 100 000 population) 
Comparable 
estimates 
 
2016 0.2 0.4 0.3 
3.a Age-standardized prevalence of tobacco 
smoking among persons 15 years and 
older u (%) 
Comparable 
estimates 
Males 2016 17.9 13.5 - 
Females 10.1 4.7 - 
3.b.1 Diphtheria-tetanus-pertussis (DTP3) 
immunization coverage among 1-year-
olds v(%) 
Comparable 
estimates 
 
2016 86 91 84 
Measles-containing-vaccine second-dose 
(MCV2) immunization coverage by the 
nationally recommended age v (%) 
Comparable 
estimates 
 
2016 72 87 53 
Pneumococcal conjugate third dose 
(PCV3) immunization coverage among 1-
year olds v (%) 
Comparable 
estimates 
 
2016 94 89 7 
3.b.2 Total net official development assistance 
to medical research and basic health per 
capita w (US$), by recipient country 
Primary data 
 
2016 0.03 0.07 0.00 
3.c Density of physicians x  (per 1000 
population) 
Primary data 
 
2007–
2016 
1.9 1.8 - 
Density of nursing and midwifery 
personnel x (per 1000 population) 
Primary data 
 
2007–
2016 
7.4 1.1 - 
Density of dentistry personnel x                     
(per 1000 population) 
Primary data 
 
2007–
2016 
1.2 1.0 - 
Density of pharmaceutical personnel x 
(per 1000 population) 
Primary data 
 
2007–
2016 
0.7 - - 
3.d Average of 13 International Health 
Regulations core capacity scores y 
Other data 
 
2010–
2017 
96 88 94 
1.a Domestic general government health 
expenditure (GGHE-D) as percentage of 
general government expenditure (GGE) 
d,z (%) 
Comparable 
estimates 
 
2015 7.7 12.2 3.1 
2.2 Prevalence of stunting in children under 
five aa (%) 
Primary data 
 
2007-
2016 
7.1 12.7 13.4 
      
an 
Prevalence of wasting in children under 
five aa (%) 
Primary data 
 
2007-
2016 
1.6 0.9 4.1 
      
an 
Prevalence of overweight in children 
under five aa (%) 
Primary data 
 
2007-
2016 
7.3 4.8 6.4 
       
an 
6.1 Proportion of population using safely 
managed drinking-water services ab (%) 
Comparable 
estimates 
 
2015 - 71 - 
6.2 Proportion of population using safely 
managed sanitation services ab (%) 
Comparable 
estimates 
 
2015 39 20 19 
7.1 Proportion of population with primary 
reliance on clean fuels t (%) 
Comparable 
estimates 
 
2016 >95 92 >95 
11.6 Annual mean concentrations of fine 
particulate matter (PM2.5) in urban areas t  
(µg/m3) 
Comparable 
estimates 
 
2016 11.8 17.2 16.8 
13.1 Average death rate due to natural 
disasters c,m,ac (per 100 000 population) 
Comparable 
estimates 
 
2012-
2016 
<0.1 0.3 <0.1 
16.1 Mortality rate due to homicide c,m (per 
100 000 population) 
Comparable 
estimates 
 
2016 31.3 43.1 49.2 
Estimated direct deaths from major 
conflicts c,m,ac,ad (per 100 000 population) 
Comparable 
estimates 
 
2012-
2016 
0.3 0.5 0.3 
17.19.2 Completeness of cause-of-death data 
c,m,ae (%) 
Comparable 
estimates 
 
2007-
2016 
97 79 89 
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Footnotes:  
a World Population Prospects: the 2017 revision. New York (NY): United 
Nations, Department of Economic and Social Affairs, Population Division; 2017. 
b "Global Health Estimates 2016: Life expectancy, 2000–2016. Geneva, 
World Health Organization; 2018 (http://www.who.int/gho/mortality_burden_disease/ 
life_tables/en/)." 
c WHO Member States with a population of less than 90 000 in 2016 were not 
included in the analysis. 
d "Global Health Expenditure Database [online database]. Geneva: World 
Health Organization (http://apps.who.int/nha/database/Select/Indicators/en/, accessed 
7 April 2018). Global and regional aggregates are unweighted averages." 
e "WHO, UNICEF, UNFPA, World Bank Group and the United Nations 
Population Division. Trends in maternal mortality: 1990 to 2015. Estimates by WHO, 
UNICEF, 
UNFPA, World Bank Group and the United Nations Population Division. Geneva: World 
Health Organization; 2015 (http://www.who.int/reproductivehealth/ 
publications/monitoring/maternal-mortality-2015/en/, accessed 29 March 2018). WHO 
Member States with a population of less than 100 000 in 2015 were 
not included in the analysis." 
f "Joint UNICEF/WHO database 2018 of skilled health personnel, based on 
population-based national household survey data and routine health systems data. New 
York (NY): United Nations Children’s Fund; 2018 (https://data.unicef.org/wp-
content/uploads/2018/02/Interagency-SAB-Database_UNICEF_WHO_Apr-2018. 
xlsx)." 
g "Levels & Trends in Child Mortality. Report 2017. Estimates developed by 
the UN Inter-agency Group for Child Mortality Estimation. United Nations Children’s 
Fund, World Health Organization, World Bank and United Nations. New York (NY): 
United Nations Children’s Fund; 2017 (http://www.childmortality.org/files_ 
v21/download/IGME%20report%202017%20child%20mortality%20final.pdf, accessed 
29 March 2018)." 
h "AIDSinfo [online database]. Geneva: Joint United Nations Programme on 
HIV/AIDS (UNAIDS) (http://aidsinfo.unaids.org/, accessed 30 March 2018), and HIV/ 
AIDS [online database]. Global Health Observatory (GHO) data. Geneva: World Health 
Organization (http://www.who.int/gho/hiv/epidemic_status/incidence/ 
en/, accessed 30 March 2018)." 
i Global tuberculosis report 2017. Geneva: World Health Organization; 2017 
(http://www.who.int/tb/publications/global_report/en/, accessed 30 March 2018). 
j "World malaria report 2017. Geneva: World Health Organization; 2017 
(http://www.who.int/malaria/publications/world-malaria-report-2017/report/en/, 
accessed 30 March 2018)." 
k "Global and Country Estimates of immunization coverage and chronic HBV 
infection [online database]. Geneva: World Health Organization; 23 March 2017 
update (http://whohbsagdashboard.com/#global-strategies, accessed 30 March 2018). 
This indicator is used here as a proxy for the SDG indicator." 
l "Neglected tropical diseases [online database]. Global Health Observatory 
(GHO) data. Geneva: World Health Organization (http://www.who.int/gho/ 
neglected_diseases/en/, accessed 30 March 2018)." 
m "Global Health Estimates 2016: Deaths by cause, age, sex, by country and 
by region, 2000–2016. Geneva: World Health Organization; 2018. (http://www.who. 
int/healthinfo/global_burden_disease/estimates/en/index1.html)." 
n "WHO Global Information System on Alcohol and Health (GISAH) [online 
database]. Global Health Observatory (GHO) data. Geneva: World Health Organization 
(http://www.who.int/gho/alcohol/en/, accessed 30 March 2018)." 
o "Global status report on road safety 2015. Geneva: World Health 
Organization; 2015 (http://www.who.int/violence_injury_prevention/road_safety_ 
status/2015/en/, accessed 30 March 2018). WHO Member States with a population of less 
than 90 000 in 2015 who did not participate in the survey used to 
produce the report were not included in the analysis." 
p "Data by country, pertaining to women aged 15-49 years who were married 
or in union, extracted by WHO from World Contraceptive Use 2018 [online database]. 
New York (NY): United Nations, Department of Economic and Social Affairs, Population 
Division; 2018 (http://www.un.org/en/development/desa/population/ 
publications/dataset/contraception/wcu2018.shtml, accessed 2 May 2018). Global and 
regional aggregates are estimates for the year 2018 from: Model-based 
Estimates and Projections of Family Planning Indicators 2018. New York (NY): United 
Nations, Department of Economic and Social Affairs, Population Division; 
2018 (http://www.un.org/en/development/desa/population/theme/family-
planning/cp_model.shtml, accessed 2 May 2018)." 
q "Data by country extracted by WHO from World Fertility Data 2017 [online 
database]. New York (NY): United Nations, Department of Economic and Social 
Affairs, Population Division; November 2017 
(http://www.un.org/en/development/desa/population/publications/dataset/fertility/wfd20
17.shtml, accessed 
21 March 2018). Global and regional aggregates refer to a five-year period, 2015–2020, 
from: World Population Prospects: the 2017 Revision. New York (NY): 
United Nations, Department of Economic and Social Affairs, Population Division; 2017 
(https://esa.un.org/unpd/wpp/Download/Standard/Fertility/, accessed 
16 February 2018)." 
 
 
 
 
r "Tracking universal health coverage: 2017 global monitoring report. Geneva 
and Washington (DC): World Health Organization and the International Bank for 
Reconstruction and Development/The World Bank; 2017 
(http://apps.who.int/iris/bitstream/handle/10665/259817/9789241513555-
eng.pdf?sequence=1, 
accessed 30 March 2018). WHO Member States with a population of less than 90 000 in 
2015 were not included in the analysis." 
s "Tracking universal health coverage: 2017 global monitoring report. Geneva 
and Washington (DC): World Health Organization and the International Bank for 
Reconstruction and Development/The World Bank; 2017 
(http://apps.who.int/iris/bitstream/handle/10665/259817/9789241513555-
eng.pdf?sequence=1, 
accessed 30 March 2018). Global and regional aggregates refer to year 2010." 
t "Public health and environment [online database]. Global Health 
Observatory (GHO) data. Geneva: World Health Organization 
(http://www.who.int/gho/phe/ 
en/)." 
u WHO global report on trends in prevalence of tobacco smoking, 2nd edition. 
Geneva: World Health Organization; 2018. Upcoming. 
v "WHO/UNICEF estimates of national immunization coverage [online 
database]. July 2017 revision 
(http://www.who.int/immunization/monitoring_surveillance/ 
routine/coverage/en/index4.html, accessed 30 March 2018)." 
w "Organisation for Economic Co-operation and Development. OECD.Stat 
[online database]. Paris: Organisation for Economic Co-operation and Development 
(http://stats.oecd.org/, accessed 19 January 2018)." 
x "WHO Global Health Workforce Statistics [online database]. Global Health 
Observatory (GHO) data. Geneva: World Health Organization (http://who.int/hrh/ 
statistics/hwfstats/en/, accessed 30 March 2018). Country comparisons are affected by 
differences in the occupations included in the cadre. Please refer to the 
source for country-specific definitions and other descriptive metadata." 
y "International Health Regulations (2005) Monitoring Framework [online 
database]. Global Health Observatory (GHO) data. Geneva: WHO (http://www.who.int/ 
gho/ihr/en/). Global and regional aggregates are for the year 2017." 
z This indicator is presented here as it could constitute the health-related 
portion of the SDG indicator 1.a.2. 
aa "Levels and trends in child malnutrition. UNICEF/WHO/World Bank Group 
Joint Child Malnutrition Estimates. New York (NY), Geneva and Washington (DC): 
United Nations Children’s Fund, World Health Organization and the World Bank Group; 
2018. Global and regional aggregates are for the year 2017." 
ab "Progress on drinking water, sanitation and hygiene – 2017 update and SDG 
baselines. Geneva and New York (NY): World Health Organization and United Nations 
 Children’s Fund; 2017 (https://washdata.org/sites/default/files/documents/reports/2018-
01/JMP-2017-report-final.pdf, accessed 31 March 2018) and Water 
and sanitation [online database]. Global Health Observatory (GHO) data. Geneva: World 
Health Organization (http://www.who.int/gho/mdg/environmental_ 
sustainability/en/). Comparable estimates are only shown for countries with recent 
primary data." 
ac The death rate is an average over the five-year period. 
ad Conflict deaths include deaths due to collective violence and exclude deaths 
due to legal intervention. 
ae "Completeness was assessed relative to the de facto resident populations and 
refer to the latest available value for the period 2007–2016. Global and regional 
aggregates are for 2016." 
af "Non-standard definition. For more details see the Joint UNICEF/WHO 
database 2018 of skilled health personnel (https://data.unicef.org/wp-content/ 
uploads/2018/02/Interagency-SAB-Database_UNICEF_WHO_Apr-2018.xlsx)." 
ag Proportion of institutional births (%) used as a proxy for the SDG indicator. 
ah Updated estimate. 
ai Preliminary data. 
aj "Deviation from standard question or measurement method. For more details 
see World Contraceptive Use 2018 (http://www.un.org/en/development/desa/ 
population/publications/dataset/contraception/wcu2018.shtml)." 
ak Under country consultation as of May 2018. 
al Data refer to year 2016. Data for 2017 were submitted in a format that could 
not be included in the analysis. 
am Survey data did not cover the 0–59 months age range. Data were adjusted 
for comparability. 
an Conversion of estimates based on the old NCHS/WHO references to WHO 
Child Growth Standards when raw data were not available to allow comparability. 
ao Data are from a facility-based surveillance system, which include 80% of 
health centres in the country. 
ap Prevalence of overweight was calculated using BMI-for-age z-scores. 
aq For high-income countries with no information on clean fuel use, usage is 
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ar Completeness refers to year prior to 2012. 
as Data are from the Nutrition Survey System, which covers 25 provinces. 
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The worse scenario for health maybe, after electric 
shutdown and lack of appropriate water supplies, would 
be still to be seen. 
Due to the breakdown of health infrastructure and 
precarious public health activities, the menace of polio 
resurgence in Venezuela has been entertained [11].  
Certainly, emerging and reemerging infectious 
diseases, still under control, such as yellow fever [149-
151], onchocerciasis [14], Venezuelan equine 
encephalitis (VEE) together with emerging circulating 
viruses such as Mayaro [152-156], Madariaga or 
Oropouche viruses [157], may potentially reach 
epidemic proportions in Venezuela and could spill over 
into neighboring countries. The most common and 
effective VEE vaccine, TC-83, can no longer be bought 
or produced in Venezuela. Zoonotic diseases such as 
VEE and even foot-and-mouth disease (FMD) are at risk 
of epizootics and epidemics due to failures in vaccination 
coverage and performance. According to the Pan-
American Center for FMD (PANAFTOSA), 
phylogenetic analyses revealed that the recent 
introduction of FMD in Colombia was originated in 
Venezuela [158]. As a consequence of this, Venezuela 
was classified as a country without an OIE (Office 
International des Epizooties) official status for FMD, and 
Colombia was suspended of FMD free status [159].  
The production of this vaccine by the Agricultural 
Research Institute has halted due to restricted production 
capacity coupled with a lack of financial support. The 
risk of latent outbreaks of VEE and its potential 
international spread increases with the presence of wild 
donkeys, lack of sanitary control and persistent 
circulation of epizootic VEE strains in different sites of 
the plains and the Catatumbo region of Venezuela-
Colombia [14], which is an area considered transborder 
crossing from one country to another. FMD have been 
reported in cattle and swine in municipalities of La 
Guajira and Cesar in 2018, posing a significant 
agricultural risk to animal production and potentially 
impacting food security [160]. Many of these conditions, 
in the context of lack of research and a defunct healthcare 
system in crisis and no conditions for appropriate 
surveillance, research and control represent a major 
threat to animal health and zoonotic diseases [161, 162]. 
 
Trained People Leaving the Country: the Venezuelan 
Diaspora 
The consequences over time regarding the situation 
in Venezuela also impacts health due to the ongoing 
significant brain drain, that includes trained physicians 
and scientists [161, 163]. The year 2018, when Chile 
gave its national exam to certify doctors to work in its 
public health system, just over 5,000 applicants sat down 
to take the test. Almost half of them, 2,300, were 
physicians from Venezuela [164]. From the beginning of 
the Chávez government in 1998, highly-qualified 
medical personnel have been forced to abandon the 
country, which has contributed significantly to this 
destabilization. As reported by a survey conducted by the 
Venezuelan Physicians Association in Spain 
(AMEVESP, by its Spanish acronym), it is estimated that 
there exist approximately Venezuelan 5,000 physicians, 
a large number of them incorporated in the Spanish 
health system. The actual number of doctors living in 
other European countries remains unknown, but the 
exodus is continuing now. In 2017 the Venezuelan 
citizens were the largest group applying for their 
overseas medical degree recognition. Not to mention 
those physicians yearning to get out soon. The 
Venezuelan medical community was the first group 
severely punished by the so-called “21-century 
Socialism”. In Spain, the Association of Venezuelan 
Physicians in Spain has 1,200 members [165].  
Given this situation, that would lead to a lack of 
specialists, including infectious diseases physicians, 
probably antimicrobial resistance [166-168] is also 
significantly upraising in Venezuela with the 
implications of internationally spreading to other 
countries [169-172].  
Venezuelans are no longer happy. Venezuela’s 
ranking on the world happiness index has plummeted in 
the last five years. The World Happiness Report 2018 
ranked the happiness for 2015-2017 of Venezuela in the 
place 102° of 156 countries, but worse, it is the country 
in the whole world with the most marked change in 
happiness from 2008-2010 to 2015-2017 (place 140° of 
140 countries with changes) [173]. Many factors play a 
part in people’s wellness, and all the indicators shown 
depict how Venezuelan’s quality of life is steadily 
deteriorating. 
Poor governance has destroyed all institutional 
accountability mechanisms to power the country [174]. 
The resulting humanitarian crisis has profound 
implications in social justice including growing health 
inequities and inequalities among impoverished and 
underserved populations nationwide.   
There is an urgent need for national and international 
institutions, governments and other stakeholders to 
address the growing unmet basic needs of Venezuelans 
[5, 8, 14, 174]. The moral economy of life in Venezuela 
reveals troubling tensions in the way government 
institutions treat their citizens.  
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There is no time to wait. In Venezuela, unnecessary 
suffering and a growing number of preventable deaths 
occur every day among children, mothers, adults, and 
grandparents. 
Because of a visit by a Commission of the Office of 
the United Nations High Commissioner for Human 
Rights (OHCHR) to Venezuela, a statement by UN High 
Commissioner for Human Rights Michelle Bachelet, at 
the 40th session of the Human Rights Council, declared 
that “the health system continues to deteriorate, with a 
very significant impact on maternal mortality and 
morbidity and infant mortality” [175].  
The main limitation of a review such as this is the 
difficulty in quantifying the magnitude of health 
problems and their long-term consequences. Some of the 
indicators available in Venezuela seem similar or even 
better than those in other countries (for example, the 
incidence of TB and the suicide rate, see Table 3). 
However, this may be due to underreporting or selection 
biases (such as survivor bias). Therefore, the lack of 
reliable data is in itself a part of the problem that must be 
addressed as a priority.   
 
Conclusions 
Finally, also consequences, especially seen in 
Colombia and Brazil, would be expected to occur in 
other countries such as Ecuador, Peru, Chile, Argentina, 
Paraguay, Uruguay, Trinidad, and Tobago, United 
States, and even beyond the Americas, in Spain, given 
the efflux of Venezuelan migrants, as has been described 
[4, 53]. For example, just between 2016 and 2017, 
Uruguay noted a significant increase in the number of 
migrants from Venezuela, 7,039 people migrated and 
asked for residency, with 5,448 more in 2018, with 
estimations of around 8,500-12,000. Some calculations 
indicate that almost 40% enrolled in public schools in 
Montevideo, Uruguay is Venezuelan. Even, the 
International Organization for Migration (IOM), 
performed a survey among 399 Venezuelan migrants 
finding that over 54% of them were age 26-38 years-old, 
50.6% with university education, 30.4% from Caracas, 
58.6% entering by air, 34.1% by land and 7.3% by sea; 
74.1% arrived less than 1 year ago.  
Assessing the routes of arrival migrants moved 
through a direct flight from Caracas to Montevideo, or 
by a stop in Brazil, Colombia or Argentina, among other 
countries [176]. According to physicians in Uruguay, the 
local population does not perceive the Venezuelan 
migrants as a source of risk for infectious diseases, 
especially for vector-borne diseases, given the ecological 
conditions of the country, e.g., without vectors.  
We are barely aware of the impact of the different 
pathologies and infectious diseases to which Venezuelan 
citizens have been exposed due to the absolute loss of 
control over health, and the political chaos we have been 
in for the last 20 years. Every country that opens us its 
doors is assuming a great responsibility since it is not 
only accepting the person but also all their benefits and 
needs (Figure 3). Some of the health systems of those 
countries are neither accustomed nor prepared to receive 
such patients. That translates into congestion in health 
care services and additional expenses [177]. We are 
jointly responsible not only as health personnel but also 
as a society for calamities such as those described in this 
document. Massive migrations through wars, famines 
and authoritarian governments affect all inhabitants of 
the planet. 
In conclusion, there is an increase in the demand for 
health services by migrants from Venezuela in the 
receiving countries. This tendency is observed 
concerning multiple health problems and the 
mechanisms involved are difficult to quantify but they 
seem to be the result of different aspects of the 
humanitarian crisis. This issue represents a public health 
alert that requires prioritization by the international 
community for a multisectoral approach. 
 
Figure 3. Venezuelan migrants in Colombia asking for money 
at streets (Pereira, April 2, 2019).  
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